Use of atomoxetine in children and adolescents with ADHD
Progress in Neurology and Psychiatry · 2009
DOI: 10.1002/pnp.114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Neurology and Psychiatry, 2009. Verfasst von Somnath Banerjee. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Atomoxetine is a non‐stimulant drug licensed for use in the treatment of attention deficit‐hyperactivity disorder (ADHD).Dr Banerjee describes a study that was carried out over a two‐year period in the three ADHD clinics in East Kent Hospitals NHS Trust to evaluate the current practice on the use of atomoxetine in ADHD in children and adolescents. Copyright © 2009 Wiley Interface Ltd
Zitieren
APA
Banerjee, S. (2009). Use of atomoxetine in children and adolescents with ADHD. Progress in Neurology and Psychiatry. https://doi.org/10.1002/pnp.114
Vancouver
Banerjee S. Use of atomoxetine in children and adolescents with ADHD. Progress in Neurology and Psychiatry. 2009. doi:10.1002/pnp.114
BibTeX
@article{Banerjee2009,
author = {Banerjee, Somnath},
title = {Use of atomoxetine in children and adolescents with ADHD},
journal = {Progress in Neurology and Psychiatry},
year = {2009},
doi = {10.1002/pnp.114}
}
EUVIMED